Navigation Links
NuVasive to Present at the Oppenheimer 20th Annual Healthcare Conference
Date:10/29/2009

SAN DIEGO, Oct. 29 /PRNewswire-FirstCall/ -- NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today that Kevin O'Boyle, Chief Financial Officer and Executive Vice President, will present at the Oppenheimer 20th Annual Healthcare Conference at The Waldorf Astoria Hotel in New York, New York, on Tuesday, November 3, 2009.

A live webcast of the presentation will be available online from the investor relations page of the Company's corporate website at www.nuvasive.com. After the live webcast, the presentation will remain available on the website for 30 days.

About NuVasive

NuVasive is a medical device company focused on the design, development, and marketing of products for the surgical treatment of spine disorders. The Company's product portfolio is focused primarily on the $4.6 billion U.S. spine implant market. Additionally, the Company has expanded into the $1.5 billion global biologics market, the $1.5 billion international market, and is developing products for the emerging motion preservation market.

NuVasive's principal product offering is based on its Maximum Access Surgery, or MAS® platform. The MAS platform combines four categories of products that collectively minimize soft tissue disruption during spine surgery with maximum visualization and safe, easy reproducibility for the surgeon: NeuroVision®, a proprietary software-driven nerve avoidance system; MaXcess®, a unique split-blade retractor system; a wide variety of specialized implants; and several biologic fusion enhancers. MAS significantly reduces surgery time and returns patients to activities of daily living much faster than conventional approaches. Having redefined spine surgery with the MAS platform's later
'/>"/>

SOURCE NuVasive, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. NuVasive Announces Conference Call and Webcast of Third Quarter 2009 Results
2. NuVasive to Present at the JMP Securities Healthcare Focus Conference
3. Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting
4. BioCryst to Present at Oppenheimer Healthcare Conference
5. Shire to Present Important Study Findings on its ADHD Treatments at a Major Psychiatric Meeting on October 29 and 30
6. Bayer and Onyx Announce Nexavar Data Presentations at 60th American Association for the Study of Liver Diseases Annual Meeting
7. Presentations of Cempra Pharmaceuticals CEM-102 (fusidic acid) at the Infectious Diseases Society of America Annual Meeting Highlight Properties That Make It an Excellent Anti-MRSA Candidate
8. Data Presented on Cempra Pharmaceuticals CEM-101 at the Infectious Diseases Society of America Annual Meeting Reinforces Potency and Coverage Against Multidrug-Resistant S. Pneumoniae Isolates
9. Cadence Pharmaceuticals CEO Ted Schroeder To Present at the Oppenheimer 20th Annual Healthcare Conference in New York City on November 4, 2009
10. Anadys Pharmaceuticals to Present at the Oppenheimer Healthcare Conference
11. Rigel Announces Presentations at Two Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015 Edwards Lifesciences Corporation (NYSE: ... heart valves and hemodynamic monitoring, today announced that Robert ... Directors. "Bob is an ardent champion for innovation ... privilege to have him on Edwards, board as we pursue ... Edwards, chairman and CEO.  "Bob has provided a valuable perspective ...
(Date:7/30/2015)... , July 30, 2015 IRIDEX Corporation (NASDAQ: ... its second quarter 2015 financial results after the market ... conjunction with the release, the Company will host a ... p.m. Eastern Time on Thursday, August 6, ... and other business developments. Interested parties may ...
(Date:7/30/2015)... 2015  EP Global Communications, Inc. (Public OTC: EPGL) announced ... the Company about discussing EPGL,s electronic contact lens ... August 3, 2015.  Novartis CEO Joe Jimenez ... coming electronic contact lens market could be worth ... several years.  Novartis partnered with Google in 2014 ...
Breaking Medicine Technology:IRIDEX Announces Second Quarter 2015 Conference Call and Release Date 2
(Date:7/31/2015)... ... 2015 , ... Recently touted by Becker’s Healthcare as one ... , Jvion continues to disrupt the predictive analytic and big data market using ... population level illness to drive prevention and better health outcomes. Most recently, Jvion ...
(Date:7/31/2015)... ... 2015 , ... Jacksonville-based drug and alcohol rehabilitation center, Lakeview ... The medical community, social workers, law enforcement, and government officials are all invited ... effort to better understand and combat sex trafficking. Lead by sex trafficking expert ...
(Date:7/31/2015)... ... ... article published July 27 on My News LA, a fire that broke out ... fire department before it caused major damage throughout the building. The article also notes that ... a fire alarm system that tipped off fire fighters so they could arrive at the ...
(Date:7/31/2015)... ... July 31, 2015 , ... As part of their company ... and support of animal welfare organizations is essential to the longevity of their business. ... in the National Association of Professional Pet Sitters (NAPPS) annual Presents 4 Pets supply ...
(Date:7/31/2015)... Athens, GA (PRWEB) , ... July 31, 2015 , ... ... help stamp out bullying across Georgia through the Girl Scout "Be a Friend First" ... program, on Thursday, July 30. , “Peach State Health Plan and our parent ...
Breaking Medicine News(10 mins):Health News:Jvion Showcased as Leader in the Predictive Analytic Market 2Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 2Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 3Health News:Article on Recent Pasadena Courtroom Fire Highlights the Effectiveness of Fire Alarm Systems, Says Fire Protection Group Inc 2Health News:Article on Recent Pasadena Courtroom Fire Highlights the Effectiveness of Fire Alarm Systems, Says Fire Protection Group Inc 3Health News:Dallas-based Park Cities Pet Sitter Selects Non-Profit Animal Welfare Organization “Angie’s Friends” as this Year’s Recipient of their Presents 4 Pets Supply Drive. 2Health News:Dallas-based Park Cities Pet Sitter Selects Non-Profit Animal Welfare Organization “Angie’s Friends” as this Year’s Recipient of their Presents 4 Pets Supply Drive. 3Health News:Dallas-based Park Cities Pet Sitter Selects Non-Profit Animal Welfare Organization “Angie’s Friends” as this Year’s Recipient of their Presents 4 Pets Supply Drive. 4Health News:Peach State Health Plan Presents $10,000 Check for “Be a Friend First” Anti-Bullying Program to Local Girl Scouts 2
... , , , ... Clinically Superior When Its Own FDA-Approved Label Said Otherwise; First-Ever ... , PHILADELPHIA, Sept. 2 Pfizer Inc. ignored a ... clinically superior to the significantly less expensive, generic vancomycin when its ...
... , , , ... DIET ), a leading provider of online weight loss services, ... creative boutique that specializes in DRTV commercials, to lead creative turnaround beginning ... service. , , "We are really impressed by ...
... 2 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE Amex:, ... China, announced,today that it has signed an agreement with ... collaborate on marketing,efforts and possible vaccine supply efforts to ... The agreement follows meetings between ...
... of the body,s immune system in the development of diseases ... skin cancer), type 1 diabetes, autoimmune liver disease, and in ... paved the way for a pioneering research programme which aims ... find ways to extract specific cells which play a role ...
... , , , , ... STRM ) announced today that it will release second quarter ... on Wednesday, September 9, 2009 after the market closes. The Company will ... Wednesday, September 9 at 4:30 p.m. ET. , , ...
... Sept. 2 BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) today ... of BioMarin, will present a company update at the Thomas Weisel Partners ... ET. , , Interested parties may access ... of the BioMarin website, www.BMRN.com . A replay ...
Cached Medicine News:Health News:Sheller, P.C. Law Firm Instrumental in Pfizer's $2.3 Billion Settlement Today in Largest Pharmaceutical Whistleblower Case in History 2Health News:Sheller, P.C. Law Firm Instrumental in Pfizer's $2.3 Billion Settlement Today in Largest Pharmaceutical Whistleblower Case in History 3Health News:Sheller, P.C. Law Firm Instrumental in Pfizer's $2.3 Billion Settlement Today in Largest Pharmaceutical Whistleblower Case in History 4Health News:Sheller, P.C. Law Firm Instrumental in Pfizer's $2.3 Billion Settlement Today in Largest Pharmaceutical Whistleblower Case in History 5Health News:eDiets.com Selects Karlin+Pimsler to Lead Creative Turnaround 2Health News:Sinovac Announces Supply Agreement with Boryung Pharmaceutical Company Limited in South Korea 2Health News:Sinovac Announces Supply Agreement with Boryung Pharmaceutical Company Limited in South Korea 3Health News:Biomedical Research Centre developing enhanced cells as therapies 2Health News:Biomedical Research Centre developing enhanced cells as therapies 3Health News:Streamline Health to Announce Second Quarter Fiscal Year 2009 Financial Results on Wednesday, September 9, 2009 2Health News:Streamline Health to Announce Second Quarter Fiscal Year 2009 Financial Results on Wednesday, September 9, 2009 3Health News:BioMarin to Present at the Thomas Weisel Partners Healthcare Conference 2
... System RS 800 can sort different specimen ... sorting are not necessary anymore and all ... a very timesaving and economical way ... a Tube Type Identification via Cap Recognition ...
... detect sequences of the following viruses: ... and 3; influenza virus A and ... and B. Laboratories may use ... *Analyte Specific Reagents. Analytical ...
... Alert Detection Reagents provide molecular labs a ... assays. By using our MGB technology, combined ... is now able to provide molecular labs ... sequences of specific organisms or genetic mutations ...
... for the detection of two genetic ... mutation on the Factor V (Leiden) ... the Prothrombin gene. Laboratories may use ... *Analyte Specific Reagents. Analytical ...
Medicine Products: